Industries > Pharma > Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases

PUBLISHED: 11 July 2017
PAGES: 188
PRODUCT CODE: PHA0210

Clear
WOOCS 2.2.1

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 188-page report you will receive 145 charts – all unavailable elsewhere.

The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Pharma Clinical Trial Services Market forecasts from 2017-2027

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW
• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles IMS Holdings Inc.
• LabCorp (Covance Inc.)
• Pharmaceutical Product Development (PPD), LLC
• Parexel International Corporation
• ICON
• INC Research
• inVentiv Health
• PRA Health Sciences
• Chiltern International
• Charles River Laboratories

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category